Clinical Trials Directory

Trials / Conditions / Malignant Pleural Effusions

Malignant Pleural Effusions

9 registered clinical trials studyying Malignant Pleural Effusions — 2 currently recruiting.

StatusTrialSponsorPhase
CompletedQuantitative C-Reactive Protein for Differentiating Tuberculous and Malignant Pleural Effusion: a Cross-Sectio
NCT06729931
Maharajgunj Medical Campus—
RecruitingA Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
NCT05543330
Wuhan YZY Biopharma Co., Ltd.Phase 1 / Phase 2
CompletedStudy With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusion
NCT03869697
Clover Biopharmaceuticals AUS PtyPhase 1
TerminatedIndwelling Pleural Catheter With Either Doxycycline or Saline at Day 7 for Pleurodesis
NCT02623959
M.D. Anderson Cancer CenterPhase 4
CompletedA Pilot Study Evaluating the Safety and Effectiveness of a New Pleural Catheter for the Medical Management of
NCT02227732
C. R. BardN/A
Enrolling By InvitationBiomarker Levels During Indwelling Pleural cAtheter Sample Testing
NCT02092155
Johns Hopkins University—
CompletedA Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effu
NCT00758316
Singapore General HospitalPhase 3
UnknownA Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis
NCT00430664
Post Graduate Institute of Medical Education and Research, ChandigarhN/A
CompletedA Quality of Life Study re Management of Malignant Pleural Effusions
NCT00188474
University Health Network, Toronto—